{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:35:29Z","timestamp":1792978529681,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["#12-MED2226-46"],"award-info":[{"award-number":["#12-MED2226-46"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004919","name":"King Abdulaziz City for Science and Technology","doi-asserted-by":"publisher","award":["#11-MED2101-46"],"award-info":[{"award-number":["#11-MED2101-46"]}],"id":[{"id":"10.13039\/501100004919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-21-1-0084"],"award-info":[{"award-number":["W81XWH-21-1-0084"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["PC200150"],"award-info":[{"award-number":["PC200150"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["KC210042\/W81XWH-22-1-0455"],"award-info":[{"award-number":["KC210042\/W81XWH-22-1-0455"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Breast cancer patients from the indigenous Arab population present much earlier than patients from Western countries and have traditionally been underrepresented in cancer genomics studies. The contribution of polygenic and Mendelian risk toward the earlier onset of breast cancer in the population remains elusive.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We performed low-pass whole genome sequencing (lpWGS) and whole-exome sequencing (WES) from 220 female breast cancer patients unselected for positive family history from the indigenous Arab population. Using publicly available resources, we imputed population-specific variants and calculated breast cancer burden-sensitive polygenic risk scores (PRS). Variant pathogenicity was also evaluated on exome variants with high coverage.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Variants imputed from lpWGS showed high concordance with paired exome (median dosage correlation: 0.9459, Interquartile range: 0.9410\u20130.9490). After adjusting the PRS to the Arab population, we found significant associations between PRS performance in risk prediction and first-degree relative breast cancer history prediction (Spearman rho=0.43, <jats:italic>p<\/jats:italic> = 0.03), where breast cancer patients in the top PRS decile are 5.53 (95% CI 1.76\u201317.97, <jats:italic>p<\/jats:italic> = 0.003) times more likely also to have a first-degree relative diagnosed with breast cancer compared to those in the middle deciles. In addition, we found evidence for the genetic liability threshold model of breast cancer where among patients with a family history of breast cancer, pathogenic rare variant carriers had significantly lower PRS than non-carriers (<jats:italic>p<\/jats:italic> = 0.0205, Mann-Whitney <jats:italic>U<\/jats:italic> test) while for non-carriers every standard deviation increase in PRS corresponded to 4.52 years (95% CI 8.88\u20130.17, <jats:italic>p<\/jats:italic> = 0.042) earlier age of presentation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Overall, our study provides a framework to assess polygenic risk in an understudied population using lpWGS and identifies common variant risk as a factor independent of pathogenic variant carrier status for earlier age of onset of breast cancer among indigenous Arab breast cancer patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13073-023-01220-4","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:02:26Z","timestamp":1693580546000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients"],"prefix":"10.1186","volume":"15","author":[{"given":"Mohammed","family":"Al-Jumaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoyin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Alsulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Y.","family":"Camp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seunghun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riaz","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Al Marzooq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatmah","family":"Almulhim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittibabu","family":"Vatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areej","family":"Al Nemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afnan","family":"Almuhanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer M.","family":"Van Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amein","family":"Al-Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9062-3399","authenticated-orcid":false,"given":"Saud H.","family":"AlDubayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"1220_CR1","doi-asserted-by":"publisher","first-page":"D1005","DOI":"10.1093\/nar\/gky1120","volume":"47","author":"A Buniello","year":"2019","unstructured":"Buniello A, MacArthur JAL, Cerezo M, Harris LW, Hayhurst J, Malangone C, et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 2019;47:D1005-12.","journal-title":"Nucleic Acids Res."},{"key":"1220_CR2","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alf\u00f6ldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature."},{"key":"1220_CR3","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13073-020-00821-7","volume":"12","author":"AN Abou Tayoun","year":"2020","unstructured":"Abou Tayoun AN, Rehm HL. Genetic variation in the Middle East-an opportunity to advance the human genetics field. Genome Med. 2020;12:116.","journal-title":"Genome Med."},{"key":"1220_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/ng.3592","volume":"48","author":"EM Scott","year":"2016","unstructured":"Scott EM, Halees A, Itan Y, Spencer EG, He Y, Azab MA, et al. Characterization of Greater Middle Eastern genetic variation for enhanced disease gene discovery. Nat Genet. 2016;48:1071\u20136.","journal-title":"Nat Genet."},{"key":"1220_CR5","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2991\/j.jegh.2018.09.003","volume":"8","author":"MJ Hashim","year":"2018","unstructured":"Hashim MJ, Al-Shamsi FA, Al-Marzooqi NA, Al-Qasemi SS, Mokdad AH, Khan G. Burden of breast cancer in the Arab world: findings from Global Burden of Disease, 2016. J Epidemiol Glob Health. 2018;8:54\u20138.","journal-title":"J Epidemiol Glob Health."},{"key":"1220_CR6","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.ijsu.2010.05.012","volume":"8","author":"H Najjar","year":"2010","unstructured":"Najjar H, Easson A. Age at diagnosis of breast cancer in Arab nations. Int J Surg. 2010;8:448\u201352.","journal-title":"Int J Surg."},{"key":"1220_CR7","doi-asserted-by":"publisher","first-page":"14111","DOI":"10.1038\/s41598-019-50680-5","volume":"9","author":"E Bidoli","year":"2019","unstructured":"Bidoli E, Virdone S, Hamdi-Cherif M, Toffolutti F, Taborelli M, Panato C, et al. Worldwide age at onset of female breast cancer: a 25-year population-based cancer registry study. Sci Rep. 2019;9:14111.","journal-title":"Sci Rep."},{"key":"1220_CR8","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S1470-2045(21)00752-X","volume":"23","author":"M Saad","year":"2022","unstructured":"Saad M, Mokrab Y, Halabi N, Shan J, Razali R, Kunji K, et al. Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study. Lancet Oncol. 2022;23:341\u201352.","journal-title":"Lancet Oncol."},{"key":"1220_CR9","doi-asserted-by":"publisher","first-page":"3328","DOI":"10.1038\/s41467-019-11112-0","volume":"10","author":"L Duncan","year":"2019","unstructured":"Duncan L, Shen H, Gelaye B, Meijsen J, Ressler K, Feldman M, et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat Commun. 2019;10:3328.","journal-title":"Nat Commun."},{"key":"1220_CR10","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","volume":"51","author":"AR Martin","year":"2019","unstructured":"Martin AR, Kanai M, Kamatani Y, Okada Y, Neale BM, Daly MJ. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat Genet. 2019;51:584\u201391.","journal-title":"Nat Genet."},{"key":"1220_CR11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajhg.2021.03.012","volume":"108","author":"AR Martin","year":"2021","unstructured":"Martin AR, Atkinson EG, Chapman SB, Stevenson A, Stroud RE, Abebe T, et al. Low-coverage sequencing cost-effectively detects known and novel variation in underrepresented populations. Am J Hum Genet. 2021;108:656\u201368.","journal-title":"Am J Hum Genet."},{"key":"1220_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1101\/gr.266486.120","volume":"31","author":"JH Li","year":"2021","unstructured":"Li JH, Mazur CA, Berisa T, Pickrell JK. Low-pass sequencing increases the power of GWAS and decreases measurement error of polygenic risk scores compared to genotyping arrays. Genome Res. 2021;31:529\u201337.","journal-title":"Genome Res."},{"key":"1220_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12864-021-07508-2","volume":"22","author":"K Wasik","year":"2021","unstructured":"Wasik K, Berisa T, Pickrell JK, Li JH, Fraser DJ, King K, et al. Comparing low-pass sequencing and genotyping for trait mapping in pharmacogenetics. BMC Genomics. 2021;22:197.","journal-title":"BMC Genomics."},{"key":"1220_CR14","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13073-019-0682-2","volume":"11","author":"JR Homburger","year":"2019","unstructured":"Homburger JR, Neben CL, Mishne G, Zhou AY, Kathiresan S, Khera AV. Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores. Genome Med. 2019;11:74.","journal-title":"Genome Med."},{"key":"1220_CR15","unstructured":"Toolkit P. Picard toolkit. Broad Institute, Github Repository. 2019; Available from: https:\/\/broadinstitute.github.io\/picard\/."},{"key":"1220_CR16","doi-asserted-by":"publisher","unstructured":"Birger C, Hanna M, Salinas E, Neff J, Saksena G, Livitz D, et al. FireCloud, a scalable cloud-based platform for collaborative genome analysis: strategies for reducing and controlling costs. bioRxiv. 2017 [cited 2022 Feb 13]. p. 209494. Available from: https:\/\/www.biorxiv.org\/content\/https:\/\/doi.org\/10.1101\/209494v1.","DOI":"10.1101\/209494v1"},{"key":"1220_CR17","unstructured":"Van der Auwera GA, O\u2019Connor BD. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. \u201cO\u2019Reilly Media, Inc.\u201d; 2020."},{"key":"1220_CR18","unstructured":"Data pre-processing for variant discovery. GATK. [cited 2022 Oct 10]. Available from: https:\/\/gatk.broadinstitute.org\/hc\/en-us\/articles\/360035535912-Data-pre-processing-for-variant-discovery."},{"key":"1220_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/nbt.4235","volume":"36","author":"R Poplin","year":"2018","unstructured":"Poplin R, Chang P-C, Alexander D, Schwartz S, Colthurst T, Ku A, et al. A universal SNP and small-indel variant caller using deep neural networks. Nat Biotechnol. 2018;36:983\u20137.","journal-title":"Nat Biotechnol."},{"key":"1220_CR20","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1001\/jama.2020.20457","volume":"324","author":"SH AlDubayan","year":"2020","unstructured":"AlDubayan SH, Conway JR, Camp SY, Witkowski L, Kofman E, Reardon B, et al. Detection of pathogenic variants with germline genetic testing using deep learning vs standard methods in patients with prostate cancer and melanoma. JAMA. 2020;324:1957\u201369.","journal-title":"JAMA."},{"key":"1220_CR21","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41436-020-01074-w","volume":"23","author":"SY Camp","year":"2021","unstructured":"Camp SY, Kofman E, Reardon B, Moore ND, Al-Rubaish AM, Aljumaan M, et al. Evaluating the molecular diagnostic yield of joint genotyping-based approach for detecting rare germline pathogenic and putative loss-of-function variants. Genet Med. 2021;23:918\u201326.","journal-title":"Genet Med."},{"key":"1220_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13059-016-0974-4","volume":"17","author":"W McLaren","year":"2016","unstructured":"McLaren W, Gil L, Hunt SE, Riat HS, Ritchie GRS, Thormann A, et al. The Ensembl Variant Effect Predictor. Genome Biol. 2016;17:122.","journal-title":"Genome Biol."},{"key":"1220_CR23","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the Catalogue Of Somatic Mutations In Cancer. Nucleic Acids Res. 2019;47:D941-7.","journal-title":"Nucleic Acids Res."},{"key":"1220_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405\u201324.","journal-title":"Genet Med."},{"key":"1220_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41588-020-00756-0","volume":"53","author":"S Rubinacci","year":"2021","unstructured":"Rubinacci S, Ribeiro DM, Hofmeister RJ, Delaneau O. Efficient phasing and imputation of low-coverage sequencing data using large reference panels. Nat Genet. 2021;53:120\u20136.","journal-title":"Nat Genet."},{"key":"1220_CR26","doi-asserted-by":"crossref","unstructured":"Loh P-R, Danecek P, Palamara PF, Fuchsberger C, A Reshef Y, K Finucane H, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48:1443\u20138.","DOI":"10.1038\/ng.3679"},{"key":"1220_CR27","doi-asserted-by":"crossref","unstructured":"1000 Genomes Project Consortium, Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","DOI":"10.1038\/nature15393"},{"key":"1220_CR28","doi-asserted-by":"publisher","unstructured":"Yun T, Li H, Chang P-C, Lin MF, Carroll A, McLean CY. Accurate, scalable cohort variant calls using DeepVariant and GLnexus. Bioinformatics. 2021; Available from: http:\/\/dx.doi.org\/https:\/\/doi.org\/10.1093\/bioinformatics\/btaa1081.","DOI":"10.1093\/bioinformatics\/btaa1081"},{"key":"1220_CR29","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet."},{"key":"1220_CR30","doi-asserted-by":"publisher","first-page":"4192","DOI":"10.1038\/s41467-021-24485-y","volume":"12","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Priv\u00e9 F, Vilhj\u00e1lmsson B, Speed D. Improved genetic prediction of complex traits from individual-level data or summary statistics. Nat Commun. 2021;12:4192.","journal-title":"Nat Commun."},{"key":"1220_CR31","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","volume":"28","author":"L Hao","year":"2022","unstructured":"Hao L, Kraft P, Berriz GF, Hynes ED, Koch C, Korategere V Kumar P, et al. Development of a clinical polygenic risk score assay and reporting workflow. Nat Med. 2022;28:1006\u201313.","journal-title":"Nat Med."},{"key":"1220_CR32","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.ajhg.2020.08.025","volume":"107","author":"LG Fritsche","year":"2020","unstructured":"Fritsche LG, Patil S, Beesley LJ, VandeHaar P, Salvatore M, Ma Y, et al. Cancer PRSweb: an online repository with polygenic risk scores for major cancer traits and their evaluation in two independent biobanks. Am J Hum Genet. 2020;107:815\u201336.","journal-title":"Am J Hum Genet."},{"key":"1220_CR33","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","volume":"12","author":"C Sudlow","year":"2015","unstructured":"Sudlow C, Gallacher J, Allen N, Beral V, Burton P, Danesh J, et al. UK biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age. PLoS Med. 2015;12:e1001779.","journal-title":"PLoS Med."},{"key":"1220_CR34","doi-asserted-by":"publisher","unstructured":"Zawistowski M, Fritsche LG, Pandit A, Vanderwerff B, Patil S, Schmidt EM, et al. The Michigan Genomics Initiative: a biobank linking genotypes and electronic clinical records in Michigan Medicine patients. bioRxiv. 2021. Available from: http:\/\/medrxiv.org\/lookup\/doi\/https:\/\/doi.org\/10.1101\/2021.12.15.21267864.","DOI":"10.1101\/2021.12.15.21267864"},{"key":"1220_CR35","unstructured":"Liftover. Available from: https:\/\/github.com\/jeremymcrae\/liftover."},{"key":"1220_CR36","unstructured":"Hail 0.2.98. Available from: https:\/\/github.com\/hail-is\/hail\/releases\/tag\/0.2.98."},{"key":"1220_CR37","doi-asserted-by":"crossref","unstructured":"Fay MP. Confidence intervals that match Fisher\u2019s exact or Blaker's exact tests. Biostatistics. 2010. p. 373\u20134. Available from: https:\/\/www.niaid.nih.gov\/about\/brb-staff-fay.","DOI":"10.1093\/biostatistics\/kxp050"},{"key":"1220_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1148\/radiology.143.1.7063747","volume":"143","author":"JA Hanley","year":"1982","unstructured":"Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29\u201336.","journal-title":"Radiology."},{"key":"1220_CR39","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.21105\/joss.03021","volume":"6","author":"M Waskom","year":"2021","unstructured":"Waskom M. seaborn: statistical data visualization. J Open Source Softw. 2021;6:3021.","journal-title":"J Open Source Softw."},{"key":"1220_CR40","doi-asserted-by":"crossref","unstructured":"Seabold S, Perktold J. Statsmodels: Econometric and statistical modeling with python. Proceedings of the 9th Python in Science Conference. SciPy; 2010. Available from: https:\/\/conference.scipy.org\/proceedings\/scipy2010\/seabold.html.","DOI":"10.25080\/Majora-92bf1922-011"},{"key":"1220_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1093\/jamiaopen\/ooy012","volume":"1","author":"TJ Pollard","year":"2018","unstructured":"Pollard TJ, Johnson AEW, Raffa JD, Mark RG. tableone: an open source Python package for producing summary statistics for research papers. JAMIA Open. 2018;1:26\u201331.","journal-title":"JAMIA Open."},{"key":"1220_CR42","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ajhg.2018.11.002","volume":"104","author":"N Mavaddat","year":"2019","unstructured":"Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, et al. Polygenic risk scores for prediction of breast cancer and breast cancer subtypes. Am J Hum Genet. 2019;104:21\u201334.","journal-title":"Am J Hum Genet."},{"key":"1220_CR43","volume-title":"Wiley StatsRef: Statistics Reference Online","author":"B Neale","year":"2014","unstructured":"Neale B. Wiley StatsRef: Statistics Reference Online. Chichester: Wiley, Ltd; 2014. https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9781118445112.stat06439."},{"key":"1220_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s40471-014-0023-3","volume":"1","author":"NR Wray","year":"2014","unstructured":"Wray NR, Maier R. Genetic basis of complex genetic disease: the contribution of disease heterogeneity to missing heritability. Curr Epidemiol Rep. 2014;1:220\u20137.","journal-title":"Curr Epidemiol Rep"},{"key":"1220_CR45","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1038\/s41591-021-01549-6","volume":"27","author":"Polygenic Risk Score Task Force of the International Common Disease Alliance","year":"2021","unstructured":"Polygenic Risk Score Task Force of the International Common Disease Alliance. Responsible use of polygenic risk scores in the clinic: potential benefits, risks and gaps. Nat Med. 2021;27:1876\u201384.","journal-title":"Nat Med."},{"key":"1220_CR46","doi-asserted-by":"publisher","first-page":"6383","DOI":"10.1038\/s41467-020-19966-5","volume":"11","author":"N Mars","year":"2020","unstructured":"Mars N, Wid\u00e9n E, Kerminen S, Meretoja T, Pirinen M, Della Briotta Parolo P, et al. The role of polygenic risk and susceptibility genes in breast cancer over the course of life. Nat Commun. 2020;11:6383.","journal-title":"Nat Commun."},{"key":"1220_CR47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1186\/s12885-022-09780-1","volume":"22","author":"J Borde","year":"2022","unstructured":"Borde J, Laitman Y, Bl\u00fcmcke B, Niederacher D, Weber-Lassalle K, Sutter C, et al. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1\/2 pathogenic variant carriers. BMC Cancer. 2022;22:706.","journal-title":"BMC Cancer."},{"key":"1220_CR48","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","volume":"26","author":"N Mars","year":"2020","unstructured":"Mars N, Koskela JT, Ripatti P, Kiiskinen TTJ, Havulinna AS, Lindbohm JV, et al. Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers. Nat Med. 2020;26:549\u201357.","journal-title":"Nat Med."},{"key":"1220_CR49","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41588-022-01054-7","volume":"54","author":"Y Ruan","year":"2022","unstructured":"Ruan Y, Lin Y-F, Feng Y-CA, Chen C-Y, Lam M, Guo Z, et al. Improving polygenic prediction in ancestrally diverse populations. Nat Genet. 2022;54:573\u201380.","journal-title":"Nat Genet."},{"key":"1220_CR50","unstructured":"Chu H. MID_lpWGS_Breast_Cancer: The code and data repository for the Middle Eastern Breast Cancer Patients lpWGS project. Github; [cited 2023 Aug 5]. Available from: https:\/\/github.com\/hoyinchu\/MID_lpWGS_Breast_Cancer."},{"key":"1220_CR51","unstructured":"Glimpse: The open source diagnostics platform for the web. Github; [cited 2023 Aug 8]. Available from: https:\/\/github.com\/Glimpse\/Glimpse."}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-023-01220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-023-01220-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-023-01220-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T23:32:37Z","timestamp":1700350357000},"score":1,"resource":{"primary":{"URL":"https:\/\/genomemedicine.biomedcentral.com\/articles\/10.1186\/s13073-023-01220-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1220"],"URL":"https:\/\/doi.org\/10.1186\/s13073-023-01220-4","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"4 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the following IRB protocol (IAU-IRB#2019-01-109). All individuals in this study consented to institutional review board-approved protocols that allowed for comprehensive genetic analysis of germline samples. This study conforms to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"E.M.V.A. holds consulting roles with Tango Therapeutics, Genome Medical, Genomic Life, Enara Bio, Manifold Bio, Monte Rosa, Novartis Institute for Biomedical Research, Riva Therapeutics and Serinus Bio; he receives research support from Novartis, Bristol-Myers Squibb and Sanofi; he has equity in Tango Therapeutics, Genome Medical, Genomic Life, Syapse, Enara Bio, Manifold Bio, Microsoft, Monte Rosa, Riva Therapeutics and Serinus Bio; he has filed institutional patents on chromatin mutations, immunotherapy response, and methods for clinical interpretation. R.G. has equity in Google, Microsoft, Amazon, Apple, Moderna, Pfizer, and Vertex Pharmaceuticals. The other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}